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Abstract
Apoptosis signal-regulating kinase 1 (ASK1) is a member of the mitogen-activated protein kinase
kinase kinase family, which activates c-Jun N-terminal kinase and p38 in response to a diverse array
of stresses such as oxidative stress, endoplasmic reticulum stress and calcium influx. In the past
decade, various regulatory mechanisms of ASK1 have been elucidated, including its oxidative stress-
dependent activation. Recently, it has emerged that ASK family proteins play key roles in cancer,
cardiovascular diseases and neurodegenerative diseases. In this review, we summarize the recent
findings on ASK family proteins and their implications in various diseases.
Introduction
All living organisms are exposed to numerous physico-
chemical stressors during their lifetime, and appropriate
responses to stress at the cellular level are essential for the
maintenance of homeostasis. The mitogen-activated pro-
tein kinase (MAPK) cascades are thought to be crucial
among the major signaling pathways that regulate cellular
stress responses. However, the mechanisms by which cells
sense stresses and convert information about them into
cellular signals are poorly understood. The MAPK path-
way consists of a cascade of three protein kinases (Figure
1). These protein kinases are sequentially activated, such
that the MAPK kinase kinase (MAPKKK) phosphorylates
and activates the MAPK kinase (MAPKK), which in turn
phosphorylates and activates the MAPK. MAPKs control a
wide variety of cellular functions, including proliferation,
differentiation, migration and apoptosis. Considering
that some MAPKKKs are capable of activating multiple
MAPK modules or activating the same modules for differ-
ent durations, the diversity of the MAPKKKs may have
evolved to allow cells to integrate specific MAPK pathways
[1]. On the other hand, it has been revealed that a number
of diseases, such as cancer, cardiovascular diseases and
neurodegenerative diseases, are intimately related to stress
response mechanisms mediated by MAPK cascades. In
this review, we focus on the regulatory mechanisms of
ASK family proteins and their relations to human dis-
eases.
Regulation of ASK1 activity
ASK1 was first identified as a member of the MAPKKK
family and was found to activate the MAPKK 4 (MKK4)-
JNK and MKK3/6-p38 pathways but not the MAP/ERK
kinase (MEK)-extracellular signal-regulated kinase (ERK)
pathway (Figure 1). In vitro kinase assays revealed that
ASK1 activated MKK3/p38- and MKK4/JNK-pathways,
and directly phosphorylated MKK3, MKK4 and MKK6.
Furthermore, overexpression of ASK1 wild-type or a con-
stitutively active mutant induced apoptosis in a fetal lung
cell line [2,3]. Invertebrate orthologs of mammalian ASK
family members have been identified in Drosophila mela-
nogaster and Caenorhabditis elegans, designated as DASK1
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and NSY-1, respectively, indicating that ASK-MAPK cas-
cades are evolutionarily well conserved among species
(Figure 2) [4-6].
Homo-oligomerization and signalosome
Previous studies have revealed that ASK1 is activated by
various stresses, including oxidative stress, endoplasmic
reticulum (ER) stress and calcium influx [3,7,8]. Phospho-
rylation of Thr845 in mouse ASK1 is essential for the acti-
vation of ASK1 [9]. Thr845 is located in the activation
loop of the kinase domain and is one of the autophospho-
rylation sites (Figure 2) [10]. Under nonstress conditions,
ASK1 forms a high molecular mass complex, designated
as the ASK1 signalosome [11]. In the signalosome, ASK1
is homo-oligomerized through the C-terminal coiled-coil
domain (CCC). Following hydrogen peroxide stimula-
tion, Thr845 appears to be autophosphorylated in trans,
thereby leading to ASK1 activation. Although an ASK1
mutant lacking the CCC (ASK1ΔCCC) exhibited lower
basal kinase activity compared to wild-type, artificially
homo-oligomerized ASK1ΔCCC was autophosphorylated
and activated without any stimulation. These results sug-
gest that ASK1 homo-oligomerization is crucial to the acti-
vation of ASK1 [9].
Reciprocal regulation by thioredoxin and TRAFs
The first identified ASK1-interacting molecule was thiore-
doxin (Trx), which turned out to play an important role in
oxidative stress-induced regulation of ASK1. Trx is an oxi-
doreductase, which has a dithiol-disulfide active site and
is thought to have anti-apoptotic effects [12]. A reduced
but not oxidized form of Trx interacts noncovalently with
the N-terminus of ASK1 and suppresses ASK1 kinase activ-
ity at the basal level by inhibiting N-terminal proximity
between ASK1 molecules. ASK1ΔN, which is an N-termi-
nal truncated mutant of ASK1 lacking a Trx binding
region, is thus a constitutively active mutant and more
potently induces apoptosis in various cultured cells
[3,13,14]. Interaction between Trx and ASK1 is observed
only under reducing conditions, and Trx is oxidized and
dissociates from ASK1 when cells are exposed to oxidative
stress such as reactive oxygen species (ROS) [3]. The ROS-
The mammalian MAP kinase cascade Figure 1
The mammalian MAP kinase cascade. ASK1 and ASK2 belong to the MAPKKK family, whose members respond to vari-
ous external stimuli and initiate the MAPK cascade. There are at least 20 MAPKKKs in vertebrates that selectively phosphor-
ylate and activate MAPKKs leading to a specific activation profile of MAPK family members. The ASK family can activate the 
JNK and p38 pathways but not the ERK pathway.Cell Communication and Signaling 2009, 7:9 http://www.biosignaling.com/content/7/1/9
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dependent dissociation of Trx from ASK1 thus serves as a
molecular switch, which converts oxidative stress to a
phosphorylation-dependent signal.
Tumor necrosis factor-α receptor-associated factors
(TRAFs) are also important in the regulation of ASK1
activity. The interactions between TRAF family proteins
and ASK1 were first examined because tumor necrosis fac-
tor-α (TNF-α induced ASK1 activation [2]. Among the
TRAF family proteins, TRAF1, TRAF2, TRAF3, TRAF5 and
TRAF6 associate with ASK1, but only TRAF2, TRAF5 and
TRAF6 increase ASK1 kinase activity [15]. TRAF2 and
TRAF6 have been shown to be recruited to ASK1 in an
ROS-dependent manner [11,16]. In mouse embryonic
fibroblasts (MEFs) derived from TRAF2- or TRAF6-defi-
cient mice, the activation of ASK1 induced by hydrogen
peroxide was dramatically attenuated and both JNK and
p38 activities were also reduced [11]. These results suggest
that TRAF2 and TRAF6 play essential roles in the ROS-
dependent activation of ASK1.
As described above, ASK1 forms a large molecular mass
complex, the ASK1 signalosome, which is required for
ASK1 activity. In response to hydrogen peroxide or TNF-α,
the ASK1 signalosome forms an even higher molecular
mass complex. In TRAF6-deficient MEFs, ASK1 signalos-
ome no longer exhibited the molecular shift induced by
hydrogen peroxide, suggesting that TRAF6 (and presuma-
bly TRAF2) is required for ROS-induced formation of the
activated ASK1 signalosome [11].
Taken together, these findings indicate that in nonstress
conditions ASK1 is oligomerized through its CCC but it
remains in an inactive form by the suppressive effect of
Trx [9]. Upon ROS stimulation, Trx dissociates from
ASK1, while TRAF2 and TRAF6 are recruited to ASK1 to
form a larger molecular mass complex. Subsequently,
Schematic illustrations of ASK1 and ASK2 Figure 2
Schematic illustrations of ASK1 and ASK2. The domain structures of ASK1 and ASK2 are illustrated. The binding 
domains of Trx and TRAF exist in the N-terminus of ASK1. Two coiled-coil domains (NCC and CCC) are important for the 
homomeric interaction and the activation of ASK1. ASK2 associates with the ASK1 C-terminus, which is required to stabilize 
the ASK2 protein. In the lower part, highly conserved amino acid sequences around the activation loop of the kinase domains 
of the ASK family are aligned with orthologues of invertebrate ASK1 (DASK1: D. melanogaster, NSY-1: C. elegans). A phospho-
rylation site essential for ASK1 activation (Thr845 in mouse-ASK1) is shown in red and by a star (*). Three autophosphoryla-
tion sites identified in ASK1 are enclosed in squares.Cell Communication and Signaling 2009, 7:9 http://www.biosignaling.com/content/7/1/9
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ASK1 forms homo-oligomeric interactions through not
only the CCC but also the N-terminal coiled-coil domain
(NCC), which leads to the fully activated form of ASK1
[13,16].
Negative regulation by phosphatases
On the other hand, two protein phosphatases have been
reported to inactivate ASK1 by dephosphorylation of
Thr845 in ASK1. Protein phosphatase 5 (PP5) recognizes
activated ASK1 in response to ROS and dephosphorylates
Thr845. This mechanism functions as a negative feedback
after the activation of ASK1 [17]. Another serine/threo-
nine protein phosphatase, PP2Cε, has also been found to
be a negative regulator of ASK1 under basal conditions.
Endogenous PP2Cε interacts with ASK1, and in vitro
experiments revealed that PP2Cε retains ASK1 in the inac-
tive form by directly dephosphorylating Thr845. In
response to hydrogen peroxide or TNF-α treatment,
PP2Cε dissociates transiently from ASK1, which may con-
tribute to ASK1 activation upon these stimuli [18].
Negative regulation by 14-3-3
The 14-3-3 family consists of highly conserved multifunc-
tional phospho-serine/phospho-threonine binding pro-
teins that participate in the regulation of diverse
intracellular signal transduction systems, including sur-
vival and apoptotic signaling [19]. In ASK1 regulation, 14-
3-3 proteins bind to ASK1 via a site involving Ser966 of
ASK1 in a phospho-dependent manner and contribute to
the suppression of ASK1 kinase activity under nonstress
conditions. ASK1 S966A, which could not bind to 14-3-3
proteins, exhibited higher kinase activity than the wild-
type, and the overexpression of ASK1 S966A enhanced
cell death relative to the overexpression of the wild-type
without any stimulation in cultured cells [20]. Dephos-
phorylation of ASK1 at Ser966 was induced by hydrogen
peroxide treatment and the dissociation of 14-3-3 from
ASK1 correlated with the dephosphorylation, resulting in
the enhancement of ASK1 catalytic activity [21]. Recently,
PP2A has been suggested to be a phosphatase responsible
for the TNF-α-dependent dephosphorylation of ASK1 at
Ser966 in vascular endothelial cells. PP2A forms a com-
plex with apoptosis signal-regulating kinase1-interacting
protein 1 (AIP1) under nonstress conditions. Upon TNF-
α treatment, AIP phosphorylation is mediated by the Ser-
ine/Threonine protein kinase receptor-interacting protein
(RIP1), and AIP is recruited to ASK1 together with PP2A.
Therefore, ASK1 phospho-Ser966 is dephosphorylated by
PP2A, which leads to the dissociation of 14-3-3 proteins
from ASK1, resulting in the activation of the ASK1-JNK
pathway [22-24].
The roles of ASK1 in stress responses
TNF signaling
TNF-α treatment induces JNK activation in a TRAF2-
dependent manner [15,25]. The requirement of ASK1 for
TNF-α-induced JNK activation has been demonstrated.
The expression of a dominant-negative mutant of ASK1
(ASK1 K709R) inhibited the JNK activation induced by
TNF-α stimulation or TRAF2 overexpression in a dose-
dependent manner [15]. Furthermore, overexpression of
an ASK1 dominant-negative mutant reduced the DNA
fragmentation induced by TNF-α, suggesting that ASK1 is
necessary for TNF-α-dependent apoptosis [2]. ASK1 inter-
acts with TRAF2 not only by TNF-α treatment but also by
hydrogen peroxide treatment [11,15]. Experiments with
mouse embryonic fibroblasts (MEFs) derived from ASK1-
deficient mice revealed that ASK1 was necessary for the
sustained activation of JNK and p38 induced by TNF-α or
hydrogen peroxide. Moreover, in ASK1-deficient MEFs,
apoptosis induced by TNF-α or hydrogen peroxide was
suppressed. Treatment with the antioxidant N-acetyl-
cysteine (NAC) suppressed the TNF-α-induced ASK1 acti-
vation, the sustained activation of JNK and apoptosis,
suggesting that the generation of ROS is required for the
TNF-α-induced ASK1-JNK axis and apoptosis [3,26].
Fas signaling
On the other hand, an agonistic antibody to Fas that acti-
vates the Fas death receptor also induces ASK1 activation
through the association between ASK1 and Daxx. ASK1
has been thought to be necessary for the subsequent JNK
and p38 activation, because their activation levels after Fas
stimulation were reduced in ASK1-deficient thymocytes
(Figure 3) [26,27]. However, apoptosis induced by Fas
antibody was unaffected in the ASK1-deficient thymo-
cytes, suggesting that ASK1 is not required for Fas-induced
apoptosis in these cells [26].
TLR4 signaling
Recently, ASK1's critical role in innate immunity has been
elucidated. Toll-like receptor-4 (TLR4) recognizes lipopol-
ysaccharide (LPS), one of the major pathogen-associated
molecular patterns of Gram-negative bacteria, as a ligand
and initiates signal transduction pathways that are impor-
tant for innate immunity (Figure 3) [28]. In dendritic cells
and splenocytes derived from ASK1-deficient mice, LPS-
induced activation of p38 and production of inflamma-
tory cytokines such as interleukin-6 (IL-6) and TNF-α
were significantly inhibited, suggesting that ASK1 is
required for TLR4 signal transduction. In a manner similar
to the case with TNF-α, pre-treatment with antioxidants
such as NAC and propyl gallate reduced LPS-induced acti-
vation of both ASK1 and p38, and also reduced the pro-
duction of IL-6 in RAW264.7 macrophage-like cells
[15,26,29]. Intriguingly, ASK1-deficient mice were resist-
ant to LPS-induced septic shock. The phenotype can beCell Communication and Signaling 2009, 7:9 http://www.biosignaling.com/content/7/1/9
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explained by the fact that the serum concentrations of
TNF-α and nitric oxide (NO), principal factors responsi-
ble for septic shock, were reduced in ASK1-deficient mice,
presumably by the attenuation of TLR4 signaling [29].
Calcium signaling
Calcium signaling also activates the ASK1-p38 pathway.
In neuronal cells, the intracellular calcium ion concentra-
tion and the activity of calcium/calmodulin-dependent
protein kinase (CaMK) play pivotal roles in the regulation
of neuronal development, plasticity and behavior [30]. In
primary neurons derived from ASK1-deficient mice, p38
activation induced by calcium influx, which was evoked
by treatment with KCl or maitotoxin, was significantly
impaired [31]. FPL64176, a voltage-dependent calcium
channel (VDCC) agonist, activated ASK1 and p38, which
was attenuated by CaMKII inhibitor KN93, suggesting
that calcium signaling activates the ASK1-p38 pathway
through CaMKII activation. CaMKII was able to activate
ASK1 by increasing the phosphorylation of Thr845 in cul-
tured cells, although CaMKII failed to directly phosphor-
ylate Thr845 of ASK1 in vitro. The precise mechanism of
how CaMKII activates ASK1 remains to be elucidated (Fig-
ure 3) [8].
Extracellular ATP signaling
Recently, the involvement of the ASK1-p38 pathway in
ATP-dependent macrophage apoptosis has been eluci-
dated [32]. Besides its role as a primary source of energy
in the body, extracellular ATP acts as an intercellular sig-
nal transmitter. It has already been well established that
high concentrations of ATP (~mM) induce apoptosis in
hematopoietic cells [33,34]. ATP receptors include two
subtypes: P2X and P2Y. P2X are channel complexes,
whereas P2Y are G-protein coupled heptahelical receptors
[35,36]. Treatment with ATP induced p38- and ROS-
dependent apoptosis in RAW264.7 cells, which was sup-
pressed by the P2X7 inhibitor KN62. In ASK1-deficient
macrophages, ATP-induced p38 activation and subse-
quent apoptosis were reduced, whereas ROS production
was not reduced, suggesting that the activation of the
ASK1-p38 pathway was crucial to the mediation of ATP-
dependent apoptosis (Figure 3). It is well known that
nicotinamide adenine dinucleotide phosphate (NADPH)
Overview of signaling upstream of ASK1 and ASK2 Figure 3
Overview of signaling upstream of ASK1 and ASK2. Various stimuli activate ASK1 and ASK2. In some of these stimuli, 
ROS generation is required to activate the ASK family. The recruitment of TRAF2 and/or TRAF6 to ASK1 is also important in 
the activation. ASK1 and ASK2 can form a complex in the cell. For details, see text.Cell Communication and Signaling 2009, 7:9 http://www.biosignaling.com/content/7/1/9
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oxidase and mitochondria are two major ROS generators
in cells. In this case, the NOX2 knockdown, which is
highly expressed in macrophages among the members of
the NADPH oxidase family, resulted in the reduction of
ROS production and the attenuation of subsequent p38
activation and apoptosis induced by ATP. NADPH oxi-
dases produce ROS toward the extracellular environment.
Thereafter, ROS is considered to enter the cytosol, which
leads to ASK1 activation. Taken together, these findings
suggest that extracellular ATP binds to P2X7, and that sub-
sequent ROS-dependent activation of the ASK1-p38 path-
way appears to induce apoptosis in macrophages (Figure
3) [32].
The function of ASK2 in tumorigenesis
Shortly after the identification of ASK1, ASK2 (also desig-
nated as MAP3K6) was identified as an ASK1 binding pro-
tein using a yeast two-hybrid screen [37]. ASK2 is highly
related to ASK1, especially in the kinase domain, and
associates with ASK1 endogenously (Figure 2) [38]. While
ASK1 is ubiquitously expressed in various tissues, ASK2 is
specifically expressed in tissues that are directly exposed to
the external environment of the body, such as skin, lung
and the gastrointestinal tract [39]. Intriguingly, ASK2 pro-
tein could not be detected in MEFs or in bone marrow-
derived macrophages (BMDM) derived from ASK1-defi-
cient mice, even though the ASK2 mRNA expression level
was slightly higher than in wild-type cells. Treatment with
a proteasome inhibitor rescued endogenous ASK2 protein
from degradation in ASK1-deficient MEFs. A similar
restorative effect was observed by the exogenous expres-
sion of ASK1 wild-type or even by that of kinase-negative
mutant in ASK1-deficient MEFs. These data suggest that
ASK1 prevents ASK2 from degradation by interacting with
it in a kinase activity-independent mechanism. Although
exogenously overexpressed ASK2 possesses very low
kinase activity, co-expression with the ASK1 kinase-nega-
tive mutant confers a strong kinase activity and the ability
to induce JNK and p38 activation to ASK2. Conversely,
ASK1 phosphorylation at Thr845 can be achieved by
ASK2 kinase activity in the ASK1-ASK2 heteromeric com-
plex, eventually leading to ASK1 activation [38].
Recently, a novel function of ASK2 in skin tumorigenesis
has been elucidated along with the complex relationship
between ASK2 and ASK1 [39]. It has been suggested that
ROS accumulation is relevant to tumor initiation and pro-
motion [40]. Also, an increasing number of studies dis-
cuss the relationship between tumorigenesis and
inflammation. ASK1 is involved in the induction of apop-
tosis, which is assumed to be a crucial tumor suppression
mechanism. ASK1 is also required for the ROS-dependent
induction of proinflammatory cytokines [29].
One of the most analyzed inflammation-associated tumor
models is the two-step "initiation and promotion"
scheme for the induction of mouse skin tumor [41]. In
this model, tumor initiation is evoked by a low dose of a
genotoxic carcinogen such as 7.12-dimethyl-
benz(a)anthracene (DMBA), which does not develop can-
cer by itself. Tumor formation can be promoted only
when a tumor-promoter such as 12-O-Tetradecanoyl-
phorbol-13-acetate (TPA) is repeatedly applied to the
mouse afterwards. In this model system, the number of
papillomas was significantly higher in ASK2-deficient
mice than in wild-type mice [39].
In ASK2-deficient keratinocytes, the activation of p38 and
that of JNK induced by DMBA through ROS production
were reduced, and subsequent caspase-3 activation and
apoptosis were also attenuated. Similarly, UV-A irradia-
tion-triggered activation of p38 and JNK, which is medi-
ated by ROS accumulation, was suppressed in ASK2-
deficient keratinocytes. Subsequent cell death was also
attenuated. These results suggest that ASK2 appears to
serve as a tumor suppressor through the induction of
MAPK activation and subsequent apoptosis in ROS-accu-
mulated damaged cells. Immunohistochemical staining
of human epithelial cancer tissue provided the evidence
that ASK2 functioned as a tumor suppressor protein. That
is, the ASK2 protein expression level was significantly
reduced in the esophageal squamous cell carcinoma
(ESCC) region in epithelial tissue, although ASK2 expres-
sion was throughout the normal cell regions [39].
On the other hand, in the skin tumorigenesis model,
fewer papillomas were induced in ASK1 and ASK2 dou-
ble-deficient mice than in ASK2-deficient mice, indicating
that ASK1 counteracts to ASK2 in tumorigenesis. It has
become clear that ASK1 is required for the production of
inflammatory cytokines such as TNF-α and IL-6 in skin
induced by treatment with TPA. In summary, ASK1 and
ASK2 play opposite roles in this tumorigenesis model.
That is, ASK2 functions as a tumor suppressor by eliminat-
ing damaged cells through apoptosis in the initiation
stage; conversely, ASK1 functions as a tumor promoter in
the promotion stage by inducing inflammation (Figure 4)
[39].
ASK1 in cardiovascular diseases
In various cardiovascular diseases, including hyperten-
sion, myocardial infarction and diabetic cardiomyopathy,
individual cardiomyocytes increase in size to compensate
in cardiac functions and damaged heart tissue, in a phe-
nomenon called cardiac hypertrophy. Although cardiac
hypertrophy is an adaptive response to the initial changes
in cardiac diseases, sustained hypertrophy potentially
causes cardiac morbidity and mortality. Ventricular hyper-
trophy is characterized by myocyte gene reprogrammingCell Communication and Signaling 2009, 7:9 http://www.biosignaling.com/content/7/1/9
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and by the accumulation of extracellular matrix (ECM)
proteins, which play crucial roles in ventricular fibrosis
and remodeling [42,43].
Angiotensin II (AngII), the central product of the renin-
angiotensin system, is known to play a key role in cardio-
vascular diseases [42]. In cardiac myocytes, ASK1 is acti-
vated by AngII via angiotensin II type I receptor (AT1) in
an ROS-dependent manner and is involved in the induc-
tion of cardiac hypertrophy, which is mediated at least in
part by the activation of JNK and p38 (Figure 4) [44,45].
In ASK1-deficient mice, AngII-induced activation of JNK
and p38 was inhibited compared to that in wild-type
mice. Moreover, cardiac hypertrophy induced by AngII
was significantly suppressed in ASK1-deficient mice [44].
These data suggest that ASK1 plays an important role in
AngII signaling, leading to cardiac hypertrophy.
In obese and diabetic mice, olmesartan, an AT1 blocker,
notably prevented cardiac inflammation, cardiac intersti-
tial fibrosis, coronary arterial remodeling and vascular
endothelial dysfunction, suggesting that AngII signaling is
also involved in vascular diseases [46]. High-fat-diet-
induced diabetes provokes vascular endothelial dysfunc-
tion following the disruption of the endothelial nitric
oxide synthase (eNOS) dimer in arteries. Although the
precise mechanism is unclear, the disruption of the eNOS
dimer contributes to the generation of superoxide [47-
50]. In ASK1-deficient mice, the impairment of vascular
endothelial function by diet-induced diabetes was sup-
pressed. This beneficial phenotype was associated with
the attenuation of eNOS dimer disruption and the subse-
quent reduction in superoxide production. It is conceiva-
ble that ASK1 may be activated in diabetic mice by an Ang
II-dependent mechanism and that it accelerates eNOS dis-
ruption, resulting in superoxide accumulation and thus
Proposed mechanisms of pathogenesis of ASK family-related diseases Figure 4
Proposed mechanisms of pathogenesis of ASK family-related diseases. ASK family proteins are involved in the patho-
genesis of various diseases. Detailed roles of the ASK family in the development of individual diseases are described in the text.Cell Communication and Signaling 2009, 7:9 http://www.biosignaling.com/content/7/1/9
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the induction of vascular endothelial dysfunction and
remodeling (Figure 4) [46].
Moreover, the inhibition of ASK1 by the recombinant
adeno-associated virus (rAAV) expressing a dominant-
negative ASK1ΔN-KR mutant was capable of suppressing
heart failure progression by preventing cardiomyocyte
apoptosis even after the onset of hereditary cardiomyopa-
thy [51]. These results suggest that ASK1 is a promising
drug target for the treatment of a variety of cardiovascular
diseases.
ASK1 in neurodegenerative diseases
Recently, endoplasmic reticulum (ER) stress, which also
activates ASK1, has been suggested to be involved in a
variety of neurodegenerative diseases [52]. The ER is the
organelle where secretory or transmembrane proteins are
synthesized and folded into an appropriate configuration.
The ER also has a quality-control function with these pro-
teins; only correctly folded proteins are excreted from the
ER, while unfolded or misfolded proteins are degraded via
endoplasmic reticulum-associated protein degradation
(ERAD), which is mediated by the ubiquitin proteasome
system (UPS). The accumulation of unfolded or mis-
folded proteins in the ER is one of the major causes of ER
dysfunction [53]. These anomalous proteins induce oli-
gomerization-dependent auto-phosphorylation of PERK
and IRE1, which are transmembrane serine-threonine
kinases localized to the ER membrane, and initiate ER
stress signaling from the ER to the cytosol [54,55]. There-
fore, to prevent ER stress, it is important to preserve nor-
mal ERAD function. The malfunction of the ERAD itself is
thought to contribute to the development of ER stress and
subsequent aggravation of several neurodegenerative dis-
eases [52].
Several kinds of inherited neurodegenerative diseases are
caused by an expanded polyglutamine (polyQ) chain in
specific proteins. For example, polyQ-expanded Hunting-
tin and Ataxin-1 are observed in Huntington's disease and
spinocerebellar ataxia type-1 (SCA-1), respectively. These
abnormally expanded polyQ-containing proteins cannot
fold correctly, resulting in the formation of insoluble
intracellular inclusions [56]. The pathogenic length
polyQ (Q79) derived from carboxy-terminal fragments of
the SCA-3 protein, but not normal length polyQ (Q14),
induced ER stress by impairing proteasome activity [57].
Under such ER stress conditions, the IRE1-TRAF2-ASK1
complex was formed on the ER membrane, leading to the
activation of the ASK1-JNK pathway. In ASK1-deficient
primary neurons, JNK activation and cell death induced
by the expression of expanded polyQ are reduced, suggest-
ing that ASK1 is involved in ER stress-dependent cell
death through the activation of JNK [7].
Recently, it has been revealed that ASK1 is also involved
in motor neuron cell death in familial amyotrophic lateral
sclerosis (ALS). To date, Cu/Zn superoxide dismutase 1
(SOD1) has been thought to be involved in the majority
of familial ALS, because multiple hereditary SOD point
mutations cause motor neuron death through various cel-
lular events in diverse ways. However, the precise mecha-
nism underlying these events is still unknown [58]. In a
recent study, Derlin-1, an important component of the
ERAD machinery, which constitutes the retro-translocon
of the ER, interacted with SOD mutants but not with wild-
type SOD1. Overexpression of SOD mutants inhibited
ERAD and thereby triggered ER stress with the activation
of the IRE1-TRAF2-ASK1 pathway [59]. In the SOD1G93A
gene transgenic mouse, which exhibits a disease pheno-
type similar to that of familial ALS patients, the accumu-
lation of SOD1 G93A and the interaction between Derlin-
1 and SOD1 G93A were observed along with the onset of
the disease [60]. The region where Derlin-1 interacts with
the SOD1 mutants was narrowed down to only 12 amino
acids (designated as CT4). CT4 overexpression led to the
dissociation of SOD1 mutants from Derlin-1, presumably
through the competitive interaction with SOD1 mutants,
and consequently IRE1, PERK and ASK1 activation was
attenuated in the cells. Compared with SOD1G93A trans-
genic mice, SOD1G93A transgenic mice crossed with ASK1
-/- mice, in which the neuronal cell death in spinal cords
was ameliorated, survived longer [59].
In summary, SOD1 mutants trigger ER stress by anoma-
lous interaction with Derlin-1, and the subsequent activa-
tion of ASK1 is involved in the progression of familial
ALS. Therefore, inhibitors of the upstream signaling path-
way of ASK1, such as Derlin-CT4, or inhibitors of ASK1
itself, might be therapeutic for ALS patients [59].
In addition, it has been suggested that ASK1 may contrib-
ute to the pathology of Alzheimer's diseases and Parkin-
son's disease through the induction of neuronal cell death
[61,62]. Thus, ASK1 has the potential to become a thera-
peutic target for these neurodegenerative diseases.
Conclusion
ASK1 is a member of the MAPKKK family in a dynamic
protein kinase network. ASK1 plays significant roles in
diverse stress responses. ASK1 also plays key roles in mul-
tiple diseases, including cancer, cardiovascular diseases
and neurodegenerative diseases. ASK2 is also a unique
protein kinase that functions by forming a heteromeric
complex with ASK1 but plays an opposite role to ASK1 in
tumorigenesis. It is important to identify the similarities
and differences among ASK family proteins, including
their activation mechanisms, in order to understand the
specific roles of the individual proteins. Considering the
involvement of ASK family proteins in critical diseases atCell Communication and Signaling 2009, 7:9 http://www.biosignaling.com/content/7/1/9
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the present time, further studies on the detailed regulatory
mechanisms of the ASK family are crucial for the develop-
ment of novel therapeutic strategies.
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